Experimental Blood Test Detects Cancer up to Four Years before Symptoms Appear
The assay looks for stomach, esophageal, colorectal, lung and liver malignancies
The assay looks for stomach, esophageal, colorectal, lung and liver malignancies
RNA sequencing has shown a previously unknown dimension to the way malignant cells work—which could lead to novel treatments
Health care providers are delaying “nonessential” surgeries—and that could hurt some patients
The promise of host-response profiling
New therapies for beloved pets are getting developed in hopes of treating humans as well
The startling discovery could open up avenues for treating some aggressive tumors
Principles of evolution and natural selection drive a radical new approach to drugs and prevention strategies
At some level, yes, and new therapies could boost the body’s natural anti-cancer responses
Two men are recognized for basic research that unleashed the immune system against cancer, becoming a new pillar of therapy
Evolutionary studies indicate that the genetic changes enabling a cancer to develop arise shockingly early within the primary tumor. This discovery points to a promising new approach to therapy...
Pancreatic cancer will soon be the second-biggest cause of cancer deaths
A winner of this year’s Lasker Award talks about his work with HPV
Enhancing the body’s own immune system is leading to promising results in the battle against malignancy
Exposure to radio-frequency radiation linked to tumor formation in rats
Contrary to expectations, most metastatic tumors are seeded not by single cells from the primary tumor but by clusters of cancer cells
New animal studies explain why supposedly healthy supplements like beta-carotene could exacerbate a dread disease
By releasing the brakes that tumor cells place on the immune system, researchers are developing a new generation of more powerful treatments against malignancy
Fifty years ago, President Richard Nixon signed the National Cancer Act into law to restructure the country’s way of dealing with a leading cause of death and suffering. Here, Jeff Allen — president and CEO of Friends of Cancer Research — describes new approaches to accelerate the testing of new drugs, including advanced applications of circulating tumor DNA...
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account